[HTML][HTML] Strategies of radioiodine ablation in patients with low-risk thyroid cancer

…, D Deandreis, S Zerdoud, B Bridji… - … England Journal of …, 2012 - Mass Medical Soc
Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …

[PDF][PDF] Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography

…, A Devillers, C Sagan, L Ferrer, B Bridji… - Journal of clinical …, 2006 - researchgate.net
… Caroline Rousseau, Anne Devillers, Christine Sagan, Ludovic Ferrer, Boumédiène Bridji,
Loıc Campion, Myriam Ricaud, Emmanuelle Bourbouloux, Isabelle Doutriaux, Martine …

[PDF][PDF] Positron emission tomography with [18F] fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell …

…, P Maingon, C Duvillard, G Calais, B Bridji… - J Clin …, 2010 - researchgate.net
… Max Lonneux, Marc Hamoir, Hervé Reychler, Philippe Maingon, Christian Duvillard,
Gilles Calais, Boumédie`ne Bridji, Laurence Digue, Michel Toubeau, and Vincent Grégoire …

Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography–computerised tomography in patients with non-small-cell lung …

C Perigaud, B Bridji, JC Roussel… - European Journal of …, 2009 - academic.oup.com
Objective: Mediastinal lymph node staging determines the treatment strategy for non-small-cell
lung cancer. This study aims to evaluate prospectively the accuracy of preoperative …

Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma

E Mirallié, T Guillan, B Bridji, I Resche, C Rousseau… - Surgery, 2007 - Elsevier
BACKGROUND: 18-F-fluoro-2-deoxyglucose positron emission tomography ( 18 FDG-PET)
is useful in the detection of iodine-negative differentiated thyroid carcinoma (DTC). The aim …

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients

…, L Ferrer, C Sagan, M Ricaud, B Bridji… - European journal of …, 2011 - Springer
Purpose Regional axillary lymph node status has remained the single most independent
variable to predict prognosis both in terms of disease recurrence and survival. This study aimed …

Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3′-deoxy-3′-18F-fluorothymidine PET images in lung cancer

…, O Blagosklonov, B Bridji… - Journal of Nuclear …, 2013 - Soc Nuclear Med
As the preparation phase of a multicenter clinical trial using 18 F-fluoro-2-deoxy-d-glucose (
18 F-FDG), 18 F-fluoromisonidazole ( 18 F-FMISO), and 3′-deoxy-3′- 18 F-…

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A …

…, JF Ménard, C Rousseau, E Rio, B Bridji… - European journal of …, 2013 - Springer
Purpose FDG PET has been suggested to have predictive value in the prognosis of oesophageal
carcinoma. However, the retrospective studies reported in the literature have shown …

Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma

…, C Ansquer, A Testard, I Resche, B Bridji… - European journal of …, 2010 - Springer
Purpose The aim of this retrospective study was to evaluate the contribution of 18 F-FDG
PET to the clinical management and survival outcome of patients suspected of recurrent …

Feasibility and benefit of fluorine 18–fluoro-2-deoxyglucose–guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases

F Kraeber-Bodéré, B Cariou, C Curtet, B Bridji… - Surgery, 2005 - Elsevier
BACKGROUND: Fluorine 18–fluoro-2-deoxyglucose (FDG) positron emission tomography (
18 F-FDG PET) can be used to visualize metastases in patients with differentiated thyroid …